SkinVision
AI-powered skin cancer detection app that provides a risk assessment for uploaded skin spots and is CE-certified under EU MDR Class IIa.
Last updated: June 5, 2026
Back to directoryAI symptom analysis and triage platform that can be embedded into healthcare journeys.
Organizations that need structured patient intake and navigation before a visit.
Compare within workflow: Patient access, triage, and agents · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Infermedica as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Separate the hosted product from the Engine API: Infermedica says the Engine API itself is not intended for direct clinical use and that final device classification depends on the customer-built application and jurisdiction. |
|---|---|
| Privacy | The docs say Engine API processes de-identified symptom sets while Platform API can store personal data; verify which mode you are buying, whether anonymous mode is enabled, and how retention and access are handled contractually. |
| Evidence | Do not rely on global accuracy or validation claims alone; test triage disposition, language performance, symptom coverage, and false reassurance risk in your local population and care-routing setup. |
| Workflow | Decide whether the product is being used for intake, symptom checking, triage, or nurse-support, then define emergency scripts, escalation paths, and who owns the final recommendation. |
Infermedica describes symptom checking, triage, intake, and API-based patient navigation; its documentation distinguishes a stateless Engine API from the stateful Platform API and says the Engine API itself is not a standalone medical device.
Not for: Emergency diagnosis, unsupervised reassurance, or replacing nurse/clinician escalation.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.